Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DENDRITIC CELLS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 5722 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Molinier-Frenkel, V; Lengagne, R; Gaden, F; Hong, SS; Choppin, J; Gahery-Segard, H; Boulanger, P; Guillet, JG
      Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response

      JOURNAL OF VIROLOGY
    2. Moore, AC; Kong, WP; Chakrabarti, BK; Nabel, GJ
      Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

      JOURNAL OF VIROLOGY
    3. Dittmer, U; Race, B; Peterson, KE; Stromnes, IM; Messer, RJ; Hasenkrug, KJ
      Essential roles for CD8(+) T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression

      JOURNAL OF VIROLOGY
    4. Huarte, E; Sarobe, P; Lasarte, JJ; Brem, G; Weiss, EH; Prieto, J; Borras-Cuesta, F
      Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

      INTERNATIONAL JOURNAL OF CANCER
    5. Le Naour, F
      Contribution of proteomics to tumor immunology

      PROTEOMICS
    6. Okamoto, M; Oshikawa, T; Ohe, G; Nishikawa, H; Furuichi, S; Tano, T; Moriya, Y; Saito, M; Sato, M
      Severe impairment of anti-cancer effect of lipoteichoic acid-related molecule isolated from a penicillin-killed Streptococcus pyogenes in toll-like receptor 4-deficient mice

      INTERNATIONAL IMMUNOPHARMACOLOGY
    7. Ross, R; Reske-Kunz, AB
      The role of NO in contact hypersensitivity

      INTERNATIONAL IMMUNOPHARMACOLOGY
    8. Azuma, I; Seya, T
      Development of immunoadjuvants for immunotherapy of cancer

      INTERNATIONAL IMMUNOPHARMACOLOGY
    9. Fujiwara, H; Hamaoka, T
      Coordination of chemokine and adhesion systems in intratumoral T cell migration responsible for the induction of tumor regression

      INTERNATIONAL IMMUNOPHARMACOLOGY
    10. Kaneko, M; Kawakita, T; Yamaoka, Y; Nomoto, K
      Development of the susceptibility to oral tolerance induction in infant mice administered a herbal drug, Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang)

      INTERNATIONAL IMMUNOPHARMACOLOGY
    11. Frleta, D; Demian, D; Wade, WF
      Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo

      INTERNATIONAL IMMUNOPHARMACOLOGY
    12. Agrawal, DK; Hopfenspirger, MT; Chavez, J; Talmadge, JE
      Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model

      INTERNATIONAL IMMUNOPHARMACOLOGY
    13. Kim, KD; Choi, SC; Kim, A; Choe, YK; Choe, IS; Lim, JS
      Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction

      INTERNATIONAL IMMUNOPHARMACOLOGY
    14. Verhasselt, V; Goldman, M
      New concepts on the pathogenesis of autoimmune disease

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    15. Gilboa, E
      The risk of autoimmunity associated with tumor immunotherapy

      NATURE IMMUNOLOGY
    16. Maloy, KJ; Powrie, F
      Regulatory T cells in the control of immune pathology

      NATURE IMMUNOLOGY
    17. Akira, S; Takeda, K; Kaisho, T
      Toll-like receptors: critical proteins linking innate and acquired immunity

      NATURE IMMUNOLOGY
    18. Pasqualini, R; McDonald, DM; Arap, W
      Vascular targeting and antigen presentation

      NATURE IMMUNOLOGY
    19. Wang, H; Marsters, SA; Baker, T; Chan, B; Lee, WP; Fu, L; Tumas, D; Yan, MH; Dixit, VM; Ashkenazi, A; Grewal, IS
      TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice

      NATURE IMMUNOLOGY
    20. Dustin, ML; Dustin, LB
      The immunological relay race: B cells take antigen by synapse

      NATURE IMMUNOLOGY
    21. Lanzavecchia, A; Sallusto, F
      Antigen decoding by T lymphocytes: from synapses to fate determination

      NATURE IMMUNOLOGY
    22. Miyazaki, T; Reed, JC
      A GTP-binding adaptor protein couples TRAIL receptors to apoptosis-inducing proteins

      NATURE IMMUNOLOGY
    23. van Stipdonk, MJB; Lemmens, EE; Schoenberger, SP
      Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

      NATURE IMMUNOLOGY
    24. Smyth, MJ; Godfrey, DI; Trapani, JA
      A fresh look at tumor immunosurveillance and immunotherapy

      NATURE IMMUNOLOGY
    25. Moser, B; Loetscher, P
      Lymphocyte traffic control by chemokines

      NATURE IMMUNOLOGY
    26. Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S
      Critical role of IL-15-IL-15R for antigen-presenting cell functions in theinnate immune response

      NATURE IMMUNOLOGY
    27. Asselin-Paturel, C; Boonstra, A; Dalod, M; Durand, I; Yessaad, N; Dezutter-Dambuyant, C; Vicari, A; O'Garra, A; Biron, C; Briere, F; Trinchieri, G
      Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology

      NATURE IMMUNOLOGY
    28. Larregina, AT; Morelli, AE; Spencer, LA; Logar, AJ; Watkins, SC; Thomson, AW; Falo, LD
      Dermal-resident CD14(+) cells: differentiate into Langerhans cells

      NATURE IMMUNOLOGY
    29. Lehner, PJ; Wilkinson, GWG
      Cytomegalovirus: from evasion to suppression?

      NATURE IMMUNOLOGY
    30. Hayday, A; Theodoridis, E; Ramsburg, E; Shires, J
      Intraepithelial lymphocytes: exploring the Third Way in immunology

      NATURE IMMUNOLOGY
    31. Neutra, MR; Mantis, NJ; Kraehenbuhl, JP
      Collaboration of epithelial cells with organized mucosal lymphoid tissues

      NATURE IMMUNOLOGY
    32. Biedermann, T; Zimmermann, S; Himmelrich, H; Gumy, A; Egeter, A; Sakrauski, AK; Seegmuller, I; Voigt, H; Launois, P; Levine, AD; Wagner, H; Heeg, K; Louis, JA; Rocken, M
      IL-4 instructs T(H)1 responses and resistance to Leishmania major in susceptible BALB/c mice

      NATURE IMMUNOLOGY
    33. Stanislawski, T; Voss, RH; Lotz, C; Sadovnikova, E; Willemsen, RA; Kuball, J; Ruppert, T; Bolhuis, RLH; Melief, CJ; Huber, C; Stauss, HJ; Theobald, M
      Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

      NATURE IMMUNOLOGY
    34. Montecino-Rodriguez, E; Leathers, H; Dorshkind, K
      Bipotential B-macrophage progenitors are present in adult bone marrow

      NATURE IMMUNOLOGY
    35. Alyea, EP; Anderson, KC
      Allotransplantation for multiple myeloma

      CANCER JOURNAL
    36. Bishop, GA; McCaughan, GW
      Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy

      LIVER TRANSPLANTATION
    37. Kim, YJ; Broxmeyer, HE
      Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    38. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    39. Galili, U; Chen, ZC; Manches, O; Plumas, J; Preisler, H
      Preparation of autologous leukemia and lymphoma vaccines expressing alpha-Gal epitopes

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    40. Montecino-Rodriguez, E; Truong, LT; Henderson, AJ
      Long-term bone marrow cultures provide access to early lymphoid progenitors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    41. Nelson, PW; Mittler, JE; Perelson, AS
      Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    42. Hartigan-O'Connor, D; Kirk, CJ; Crawford, R; Mule, JJ; Chamberlain, JS
      Immune evasion by muscle-specific gene expression in dystrophic muscle

      MOLECULAR THERAPY
    43. Dan, QH; Sanchez, R; Delgado, C; Wepsic, HT; Morgan, K; Chen, YJ; Jeffes, EWB; Lowell, CA; Morgan, TR; Jadus, MR
      Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-Cell immunity against the parental tumor

      MOLECULAR THERAPY
    44. Rudginsky, S; Siders, W; Ingram, L; Marshall, J; Scheule, R; Kaplan, J
      Antitumor activity of cationic lipid complexed with immunostimulatory DNA

      MOLECULAR THERAPY
    45. Fields, PA; Arruda, VR; Armstrong, E; Chu, K; Mingozzi, F; Hagstrom, JN; Herzog, RW; High, KA
      Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9

      MOLECULAR THERAPY
    46. Schnell, MA; Zhang, Y; Tazelaar, J; Gao, GP; Yu, QC; Qian, R; Chen, SJ; Varnavski, AN; LeClair, C; Raper, SE; Wilson, JM
      Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors

      MOLECULAR THERAPY
    47. Wu, XF; He, YK; Falo, LD; Hui, KM; Huang, L
      Regression of human mammary adenocarcinoma by systemic administration of arecombinant gene encoding the hFlex-TRAIL fusion protein

      MOLECULAR THERAPY
    48. Drabick, JJ; Glasspool-Malone, J; Somiari, S; King, A; Malone, RW
      Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization

      MOLECULAR THERAPY
    49. Ziske, C; Marten, A; Schottker, B; Buttgereit, P; Schakowski, F; Gorschluter, M; von Rucker, A; Scheffold, C; Chao, N; Sauerbruch, T; Schmidt-Wolf, IGH
      Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9

      MOLECULAR THERAPY
    50. Bronte, V; Serafini, P; Apolloni, E; Zanovello, P
      Tumor-induced immune dysfunctions caused by myeloid suppressor cells

      JOURNAL OF IMMUNOTHERAPY
    51. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    52. Marten, A; Ziske, C; Schottker, B; Renoth, S; Weineck, S; Buttgereit, P; Schakowski, F; von Rucker, A; Sauerbruch, T; Schmidt-Wolf, IGH
      Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations

      JOURNAL OF IMMUNOTHERAPY
    53. Lum, LG; LeFever, AV; Treisman, JS; Garlie, NK; Hanson, JP
      Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells - Phase I clinical trial

      JOURNAL OF IMMUNOTHERAPY
    54. Nguyen, CL; Bui, JT; Demcheva, M; Vournakis, JN; Cole, DJ; Gillanders, WE
      Sustained release of granulocyte-macrophage colony-stimulating factor froma modular peptide-based cancer vaccine alters vaccine microenvironment andenhances the antigen-specific T-cell response

      JOURNAL OF IMMUNOTHERAPY
    55. Zeng, G
      MHC class II-restricted tumor antigens recognized by CD4(+) T cells: New strategies for cancer vaccine design

      JOURNAL OF IMMUNOTHERAPY
    56. Lambert, LA; Gibson, GR; Maloney, M; Barth, RJ
      Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens

      JOURNAL OF IMMUNOTHERAPY
    57. Sykes, M
      Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: Isthere a solid approach?

      JOURNAL OF IMMUNOTHERAPY
    58. Akasaki, Y; Kikuchi, T; Homma, S; Abe, T; Kofe, D; Ohno, T
      Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model

      JOURNAL OF IMMUNOTHERAPY
    59. Holmes, LM; Li, JH; Sticca, RP; Wagner, TE; Wei, YZ
      A rapid, novel strategy to induce tumor cell-specific cytotoxic T lymphocyte responses using instant dendritomas

      JOURNAL OF IMMUNOTHERAPY
    60. Weiser, TS; Guo, ZS; Ohnmacht, GA; Parkhurst, ML; Tong-On, P; Marincola, FM; Fischette, MR; Yu, XD; Chen, GA; Hong, JA; Stewart, JH; Nguyen, DM; Rosenberg, SA; Schrump, DS
      Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1

      JOURNAL OF IMMUNOTHERAPY
    61. Hoffmann, TK; Meidenbauer, N; Muller-Berghaus, J; Storkus, WJ; Whiteside, TL
      Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells

      JOURNAL OF IMMUNOTHERAPY
    62. Man, S; Fiander, A
      Immunology of human papillomavirus infection in lower genital tract neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    63. Stern, PL; Faulkner, R; Veranes, EC; Davidson, EJ
      The role of human papillomavirus vaccines in cervical neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    64. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    65. Ullenhag, G; Bird, C; Ragnhammar, P; Frodin, JE; Strigard, K; Osterborg, A; Thorpe, R; Mellstedt, H; Wadhwa, M
      Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation

      CLINICAL IMMUNOLOGY
    66. Linker-Israeli, M; Elstner, E; Klinenberg, JR; Wallace, DJ; Koeffler, HP
      Vitamin D-3 and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC

      CLINICAL IMMUNOLOGY
    67. Weiskirch, LM; Pan, ZK; Paterson, Y
      The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms

      CLINICAL IMMUNOLOGY
    68. Falcone, M; Yeung, B; Tucker, L; Rodriguez, E; Krahl, T; Sarvetnick, N
      IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic islets

      CLINICAL IMMUNOLOGY
    69. Orentas, RJ; Roskopf, SJ; Nolan, GP; Nishimura, MI
      Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide

      CLINICAL IMMUNOLOGY
    70. Chen, B; Stiff, P; Sloan, G; Kash, J; Manjunath, R; Pathasarathy, M; Oldenburg, D; Foreman, KE; Nickoloff, BJ
      Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli

      CLINICAL IMMUNOLOGY
    71. Feili-Hariri, M; Morel, PA
      Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains

      CLINICAL IMMUNOLOGY
    72. Feldman, S; Stein, D; Amrute, S; Denny, T; Garcia, Z; Kloser, P; Sun, Y; Megjugorac, N; Fitzgerald-Bocarsly, P
      Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors

      CLINICAL IMMUNOLOGY
    73. Fukami, T; Miyazaki, E; Matsumoto, T; Kumamoto, T; Tsuda, T
      Elevated expression of interleukin-18 in the granulomatous lesions of muscular sarcoidosis

      CLINICAL IMMUNOLOGY
    74. Abdel-Motal, UM; Friedline, R; Poligone, B; Pogue-Caley, RR; Frelinger, JA; Tisch, R
      Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/K-b transgenic mice

      CLINICAL IMMUNOLOGY
    75. Tekstra, J; Tjin, EPM; Tuk, CW; Broekhuis-Fluitsma, D; Havenith, CEG; Beelen, RHJ
      Analysis of monocyte chemotactic protein-1 production in different major histocompatability complex-restricted antigen presentation systems

      CLINICAL IMMUNOLOGY
    76. Reeves, WH
      Tumor immunity and autoimmunity: A case of Dr. Jekyll and Mr. Hyde

      CLINICAL IMMUNOLOGY
    77. Zeh, HJ; Stavely-O'Carroll, K; Choti, MA
      Vaccines for colorectal cancer

      TRENDS IN MOLECULAR MEDICINE
    78. Zhu, DL; Rice, J; Savelyeva, N; Stevenson, FK
      DNA fusion vaccines against B-cell tumors

      TRENDS IN MOLECULAR MEDICINE
    79. Ronnblom, L; Alm, GV
      An etiopathogenic role for the type IIFN system in SLE

      TRENDS IN IMMUNOLOGY
    80. Knolle, PA; Limmer, A
      Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells

      TRENDS IN IMMUNOLOGY
    81. Jankovic, D; Liu, ZG; Gause, WC
      Th1-and Th2-cell commitment during infectious disease: asymmetry in divergent pathways

      TRENDS IN IMMUNOLOGY
    82. Cusi, MG
      The response to plasmid DNA-virosome vaccination: a role for circulating antibodies?

      TRENDS IN IMMUNOLOGY
    83. Snapper, CM; Shen, Y; Khan, AQ; Colino, J; Zelazowski, P; Mond, JJ; Gause, WC; Wu, ZQ
      Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae

      TRENDS IN IMMUNOLOGY
    84. Wang, RF
      The role of MHC class II-restricted tumor antigens and CD4(+) T cells in antitumor immunity

      TRENDS IN IMMUNOLOGY
    85. Annunziato, F; Romagnani, P; Cosmi, L; Lazzeri, E; Romagnani, S
      Chemokines and lymphopoiesis in human thymus

      TRENDS IN IMMUNOLOGY
    86. Friedl, P; Gunzer, M
      Interaction of T cells with APCs: the serial encounter model

      TRENDS IN IMMUNOLOGY
    87. Dustin, ML; Allen, PM; Shaw, AS
      Environmental control of immunological synapse formation and duration

      TRENDS IN IMMUNOLOGY
    88. Das, PK; van den Wijngaard, RMJGJ; Wankowicz-Kalinska, A; Le Poole, IC
      A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo

      TRENDS IN IMMUNOLOGY
    89. Pohlmann, S; Baribaud, F; Doms, RW
      DC-SIGN and DC-SIGNR: helping hands for HIV

      TRENDS IN IMMUNOLOGY
    90. van Eijk, M; Defrance, T; Hennino, A; de Groot, C
      Death-receptor contribution to the germinal-center reaction

      TRENDS IN IMMUNOLOGY
    91. Wohlleben, G; Erb, KJ
      Atopic disorders: a vaccine around the corner?

      TRENDS IN IMMUNOLOGY
    92. Frucht, DM; Fukao, T; Bogdan, C; Schindler, H; O'Shea, JJ; Koyasu, S
      IFN-gamma-production by antigen-presenting cells: mechanisms emerge

      TRENDS IN IMMUNOLOGY
    93. Overwijk, WW; Restifo, NP
      Creating therapeutic cancer vaccines: notes from the battlefield

      TRENDS IN IMMUNOLOGY
    94. Barten, R; Torkar, M; Haude, A; Trowsdale, J; Wilson, MJ
      Divergent and convergent evolution of NK-cell receptors

      TRENDS IN IMMUNOLOGY
    95. Lubitz, W
      Bacterial ghosts as carrier and targeting systems

      EXPERT OPINION ON BIOLOGICAL THERAPY
    96. Morse, MA; Clay, TM; Hobeika, AC; Mosca, PJ; Lyerly, HK
      Surrogate markers of response to cancer immunotherapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    97. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    98. Eo, SK; Pack, C; Kumaraguru, U; Rouse, BT
      Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections

      EXPERT OPINION ON BIOLOGICAL THERAPY
    99. Wang, E; Phan, GQ; Marincola, FM
      T-cell-directed cancer vaccines: the melanoma model

      EXPERT OPINION ON BIOLOGICAL THERAPY
    100. Henson, PM; Bratton, DL; Fadok, VA
      The phosphatidylserine receptor: a crucial molecular switch?

      NATURE REVIEWS MOLECULAR CELL BIOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:58:42